Clinical trial
Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.
NCT00456183 · University of Oxford, Other · Completed
Key facts
| NCT number | NCT00456183 |
|---|---|
| Title | Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB. |
| Official title | A Phase I Study Evaluating the Safety and Immunogenicity of a New TB Vaccine, MVA85A, in Healthy Volunteers Who Are Latently Infected With Mycobacterium Tuberculosis. |
| Lead sponsor | University of Oxford, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Tuberculosis |
| Intervention type | Biological |
| Interventions | MVA 85A |
| Enrollment | 12 |
| Start date | Aug 1, 2005 |
| Completion | Apr 1, 2007 |
| First posted | Apr 4, 2007 |
| Last update posted | May 31, 2007 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: